5 Best Biotech Stocks to Buy According to Cathie Wood

3. CRISPR Therapeutics AG (NASDAQ: CRSP)

Number of Hedge Fund Holders: 27    

CRISPR Therapeutics AG (NASDAQ: CRSP) is a Switzerland-based biotech firm founded in 2013. It is ranked third on our list of 10 best biotech stocks to buy according to Cathie Wood. CRISPR stock has offered investors returns exceeding 68% over the past year. The company is primarily a gene-editing firm focused on the development and marketing of transformative gene-based medicines that treat a range of diseases. These medicines are developed using a technology called Clustered Regularly Interspaced Short Palindromic Repeats. 

In quarterly earnings posted on April 27, CRISPR Therapeutics AG (NASDAQ: CRSP) reported earnings per share (EPS) of -$1.51. The figure missed market predictions by $0.04. The revenue over the period was just $0.54 million, up more than 230% year-on-year.

At the end of the first quarter of 2021, 27 hedge funds in the database of Insider Monkey held stakes worth $1.4 billion in CRISPR Therapeutics AG (NASDAQ: CRSP), down from 34 in the preceding quarter worth $2 billion.

Just like Teladoc Health, Inc. (NYSE: TDOC) and Exact Sciences Corporation (NASDAQ: EXAS), CRISPR Therapeutics AG (NASDAQ: CRSP) is one of the best biotech stocks to buy according to Cathie Wood.